A Study Comparing The Safety And Efficacy Profile Of A Durable Polymer Zotarolimus-Eluting Stent (ZES) With A Biodegradable Polymer Biolimus-Eluting Stent (BES) In Patients Undergoing Percutaneous Coronary Intervention
Latest Information Update: 16 May 2017
At a glance
- Drugs Umirolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- 16 May 2017 New trial record